Many Muslims in America recently began their annual celebration of Ramadan, which for many includes fasting or long stretches without eating or drinking. This year, Ramadan began on July 9th and will end on August 7th. For Muslims with chronic illnesses, this can present significant risks.
Testifying before a congressional committee weighing options to strengthen oversight of compounding pharmacies, National Association of Boards of Pharmacy Executive Director Carmen Catizone supported legislation proposed in the U.S. Senate.
Student pharmacists from the University of Arkansas, the University of Oklahoma, and the University of the Pacific are finalists in 2013 Good Neighbor Pharmacy NCPA Pruitt-Schutte Student Business Plan Competition.
Together Rx Access’ popular prescription saving program, through which uninsured consumers saved on hundreds of brand name and generic prescriptions, will end next year.
B. Douglas Hoey, CEO of the National Community Pharmacists Association, this week testified before a congressional committee considering tightening FDA oversight of compounding pharmacies following last year’s New England Compounding Center’s fungal meningitis tragedy.
Walgreens has named Mark Lelinski, formerly an executive with Accenture and AstraZeneca, its corporate vice president, market access.
The National Association of Chain Drug Stores Foundation has announced a request-for-proposals to research integrating medication therapy management services into the hospital discharge process.
Medicare costs for more than 669,000 beneficiaries within the Pioneer Accountable Care Organizations last year grew at a slower pace, 0.3%, compared to the 0.8% growth rate in spending for those beneficiaries not part of this new model.
Within our healthcare-driven society, the increase in the identification and diagnosis of mental illnesses has led to a proportional increase in the prescribing of psychotropic medications. The prevalence of mental illnesses and subsequent treatment approaches that employ monotherapy as first-line treatment, but in many cases the use of combination of therapy can occur, leading to polypharmacy.1
Retail pharmacies have a responsibility to improve Medicare Part D Star ratings – and partner with health plans to achieve those goals, according to an executive with Target.
Face-to-face interaction between pharmacists and patients will be key to the success or failure of the federal government’s Million Hearts initiative to prevent heart attacks and strokes, Salvatore Giorgianni, PharmD, told participants during the June 3 State of Men’s Heart Webinar.
Some conclusions about pharmacy practice then and now, from an RPh who has weathered it all
Take 15 minutes and make a difference
Impressions from a working visit to McLaughlin, S.D.
Some thoughts about the things that count
A short history of biologics and biosimilars, with some pointers on what comes next
As the first biosimilar has yet to make its way through the approval process, many practical and hypothetical questions remain
What's it like to own your own pharmacy? Glad you asked
As new therapies for HIV/AIDS extend many patients' lives, pharmacists are well situated to help them manage the disease
Retail pharmacies have a responsibility to improve Medicare Part D Star ratings – and partner with health plans to achieve those goals, according to an executive with Target.
FDA advisers recommended in early June the easing of restrictions on the diabetes drug rosiglitazone (Avandia, GlaxoSmithKline), following an independent re-examination of GSK’s RECORD study conducted by Duke Clinical Research Institute.
Walgreens, the largest pharmacy chain in the United States, has agreed to pay $80 million in civil penalties for record-keeping and dispensing violations under the Controlled Substances Act, according to statements released June 11 by the company and the Drug Enforcement Agency (DEA).
Delays in treatment and medication nonadherence are the major reasons behind avoidable costs in the healthcare system, according to a new study released this week.
Results from the RELY-ABLE trial, the RE-LY extension study, support the long-term safety profile of dabigatran etexilate mesylate (Pradaxa, Boehringer Ingelheim Pharmaceuticals) 150 mg twice daily in patients with nonvalvular atrial fibrillation (NVAF), according to a study published in Circulation.
Pharmcognosy is no longer a required course in pharmacy education, although some schools offer it as an elective. The newer schools do not offer it at all. Do new student pharmacists even know the definition of the word?
Results from the RELY-ABLE trial, the RE-LY extension study, support the long-term safety profile of dabigatran etexilate mesylate (Pradaxa, Boehringer Ingelheim Pharmaceuticals) 150 mg twice daily in patients with nonvalvular atrial fibrillation (NVAF), according to a study published in Circulation in mid-June.
Less than a month after FDA warned of an outbreak following steroid injections from a compounding pharmacy there, the Tennessee Board of Pharmacy (TBOP) strengthened its oversight of compounding pharmacies.
The Community Preventive Services Task Force, an independent, uncompensated panel of public health and prevention experts, has released 3 recommendations to address risk factors for cardiovascular disease. Pharmacists were included as members of the team to help with interventions for CVD prevention.